Search company, investor...

Hemofocus ApS


Other Investors | Alive

About Hemofocus ApS

Hemofocus based in Denmark, is developing pharmacological inventions that help to decrease bleeding and thereby reduce the need for blood transfusions. Novo is the sole investor in hemofocus.

Headquarters Location

Missing: Hemofocus ApS's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Hemofocus ApS's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Hemofocus ApS Frequently Asked Questions (FAQ)

  • What is Hemofocus ApS's latest funding round?

    Hemofocus ApS's latest funding round is Other Investors.

  • Who are the investors of Hemofocus ApS?

    Investors of Hemofocus ApS include Novo Holdings.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.